Cargando…

Sustaining Vaccine Confidence in the 21st Century

Vaccination provides many health and economic benefits to individuals and society, and public support for immunization programs is generally high. However, the benefits of vaccines are often not fully valued when public discussions on vaccine safety, quality or efficacy arise, and the spread of misi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardt, Karin, Schmidt-Ott, Ruprecht, Glismann, Steffen, Adegbola, Richard A., Meurice, François P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494231/
https://www.ncbi.nlm.nih.gov/pubmed/26344109
http://dx.doi.org/10.3390/vaccines1030204
_version_ 1782380049418158080
author Hardt, Karin
Schmidt-Ott, Ruprecht
Glismann, Steffen
Adegbola, Richard A.
Meurice, François P.
author_facet Hardt, Karin
Schmidt-Ott, Ruprecht
Glismann, Steffen
Adegbola, Richard A.
Meurice, François P.
author_sort Hardt, Karin
collection PubMed
description Vaccination provides many health and economic benefits to individuals and society, and public support for immunization programs is generally high. However, the benefits of vaccines are often not fully valued when public discussions on vaccine safety, quality or efficacy arise, and the spread of misinformation via the internet and other media has the potential to undermine immunization programs. Factors associated with improved public confidence in vaccines include evidence-based decision-making procedures and recommendations, controlled processes for licensing and monitoring vaccine safety and effectiveness and disease surveillance. Community engagement with appropriate communication approaches for each audience is a key factor in building trust in vaccines. Vaccine safety/quality issues should be handled rapidly and transparently by informing and involving those most affected and those concerned with public health in effective ways. Openness and transparency in the exchange of information between industry and other stakeholders is also important. To maximize the safety of vaccines, and thus sustain trust in vaccines, partnerships are needed between public health sector stakeholders. Vaccine confidence can be improved through collaborations that ensure high vaccine uptake rates and that inform the public and other stakeholders of the benefits of vaccines and how vaccine safety is constantly assessed, assured and communicated.
format Online
Article
Text
id pubmed-4494231
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44942312015-08-31 Sustaining Vaccine Confidence in the 21st Century Hardt, Karin Schmidt-Ott, Ruprecht Glismann, Steffen Adegbola, Richard A. Meurice, François P. Vaccines (Basel) Review Vaccination provides many health and economic benefits to individuals and society, and public support for immunization programs is generally high. However, the benefits of vaccines are often not fully valued when public discussions on vaccine safety, quality or efficacy arise, and the spread of misinformation via the internet and other media has the potential to undermine immunization programs. Factors associated with improved public confidence in vaccines include evidence-based decision-making procedures and recommendations, controlled processes for licensing and monitoring vaccine safety and effectiveness and disease surveillance. Community engagement with appropriate communication approaches for each audience is a key factor in building trust in vaccines. Vaccine safety/quality issues should be handled rapidly and transparently by informing and involving those most affected and those concerned with public health in effective ways. Openness and transparency in the exchange of information between industry and other stakeholders is also important. To maximize the safety of vaccines, and thus sustain trust in vaccines, partnerships are needed between public health sector stakeholders. Vaccine confidence can be improved through collaborations that ensure high vaccine uptake rates and that inform the public and other stakeholders of the benefits of vaccines and how vaccine safety is constantly assessed, assured and communicated. MDPI 2013-06-24 /pmc/articles/PMC4494231/ /pubmed/26344109 http://dx.doi.org/10.3390/vaccines1030204 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Hardt, Karin
Schmidt-Ott, Ruprecht
Glismann, Steffen
Adegbola, Richard A.
Meurice, François P.
Sustaining Vaccine Confidence in the 21st Century
title Sustaining Vaccine Confidence in the 21st Century
title_full Sustaining Vaccine Confidence in the 21st Century
title_fullStr Sustaining Vaccine Confidence in the 21st Century
title_full_unstemmed Sustaining Vaccine Confidence in the 21st Century
title_short Sustaining Vaccine Confidence in the 21st Century
title_sort sustaining vaccine confidence in the 21st century
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494231/
https://www.ncbi.nlm.nih.gov/pubmed/26344109
http://dx.doi.org/10.3390/vaccines1030204
work_keys_str_mv AT hardtkarin sustainingvaccineconfidenceinthe21stcentury
AT schmidtottruprecht sustainingvaccineconfidenceinthe21stcentury
AT glismannsteffen sustainingvaccineconfidenceinthe21stcentury
AT adegbolaricharda sustainingvaccineconfidenceinthe21stcentury
AT meuricefrancoisp sustainingvaccineconfidenceinthe21stcentury